SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
HCV: Curing the Patient but Not the Population
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
7 of
7
|
Oral Abstract Moderator
Arthur Y. Kim
Harvard Medical School, Boston, MA, United States
Networks of HCV Transmissions Among Persons Who Inject Drugs: Indiana, 2015
Sumathi Ramachandran
Centers for Disease Control and Prevention, Atlanta, GA, United States
Hepatitis B and C, Alcohol, and CD4 Drive End-Stage Liver Disease in HIV+ Adults
Keri N. Althoff
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States
Antiretroviral Therapy Reduces Intrahepatic Hepatitis C in HIV-1/HCV Coinfection
Ashwin Balagopal
Johns Hopkins University, Baltimore, MD, United States
Broadly Neutralizing Antibodies Avert HCV ReInfection or Subsequent Chronic Infection
Sabrina J. Merat
AIMM Therapeutics, Amsterdam, Netherlands
High Response Rate in HCV-Genotype 4 Patients Treated With Ravidasvir and Sofosbuvir
Imam Waked
National Liver Institute, Shebeen El Kom, Egypt
Ledipasvir/Sofosbuvir for 6 Weeks in HIV-Infected Patients With Acute HCV Infection
Jürgen K. Rockstroh
Medizinische Universitatsklinik, Bonn, Germany
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
7 of
7
|
